Share This Page
Drug Price Trends for NDC 00093-8073
✉ Email this page to a colleague
Average Pharmacy Cost for 00093-8073
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| KELNOR 1-50 TABLET | 00093-8073-16 | 0.73821 | EACH | 2025-11-19 |
| KELNOR 1-50 TABLET | 00093-8073-28 | 0.73821 | EACH | 2025-11-19 |
| KELNOR 1-50 TABLET | 00093-8073-16 | 0.73755 | EACH | 2025-10-22 |
| KELNOR 1-50 TABLET | 00093-8073-28 | 0.73755 | EACH | 2025-10-22 |
| KELNOR 1-50 TABLET | 00093-8073-16 | 0.72722 | EACH | 2025-09-17 |
| KELNOR 1-50 TABLET | 00093-8073-28 | 0.72722 | EACH | 2025-09-17 |
| KELNOR 1-50 TABLET | 00093-8073-16 | 0.70007 | EACH | 2025-08-20 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 00093-8073
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC: 00093-8073
Introduction
The healthcare industry continually evolves, driven by innovations in pharmaceuticals, regulatory developments, and shifting market dynamics. The National Drug Code (NDC) 00093-8073 refers to a specific medication, whose market performance and pricing trajectory warrant detailed analysis. This report provides a comprehensive assessment of the current market landscape, competitive positioning, regulatory considerations, pricing trends, and future projections for this drug.
Overview of the Drug and Its Therapeutic Category
The NDC 00093-8073 corresponds to a prescription medication marketed for the treatment of [specific indication]. As part of its therapeutic class, the drug is categorized under [drug class], which typically addresses conditions such as [conditions]. The product’s formulation, delivery method, and patent status influence its market penetration and pricing.
The drug’s patent expiration date, marketed formulations, and approved indications shape its future commercial potential. Currently, this medication is positioned in the [brand name/availability status], with clinical data supporting its efficacy and safety profile.
Market Landscape
Market Size and Segmentation
The global market for [therapeutic category] was valued at approximately $X billion in 2022, with expected compound annual growth rate (CAGR) of X% over the next five years [1]. Key segments include:
- Hospital/institutional use: accounting for approximately X% of sales, driven by inpatient treatments.
- Outpatient and retail pharmacies: representing X%, primarily through retail prescriptions.
- Home healthcare: emerging due to increased convenience and patient adherence.
The target patient population is estimated at X million globally, with major markets comprising the United States, European Union, and Asia-Pacific.
Competitive Dynamics
The competitive landscape includes:
- Generic alternatives: Post-patent expiry, generics may dominate, reducing prices.
- Branded competitors: A limited number of patented or branded equivalents.
- Biosimilars or biosimilar-like products: Emerging in specific categories, potentially impacting market share.
Regulatory Environment
The regulatory environment influences market access and pricing. In the U.S., FDA approval dictates market entry, with subsequent decisions impacting pricing and reimbursement. Payer policies, coverage, and formulary placement are critical for commercial success.
Current Pricing and Reimbursement Landscape
List Price and Actual Selling Price
The wholesale acquisition cost (WAC) for NDC 00093-8073 stands at approximately $X per unit or per dose, as of Q2 2023. This list price reflects initial manufacturer suggested retail prices (MSRP) before discounts, rebates, and negotiated payer agreements.
Rebates and Discounts
Rebates typically reduce net prices paid by payers by X–X%, varying based on volume, contract terms, and formularies [2]. Manufacturers often institutionalize patient assistance programs and coupon mechanisms to enhance market access.
Reimbursement Trends
Reimbursement coverage depends on the drug's approved labeling, perceived value, and cost-effectiveness analyses. CMS, private insurers, and pharmacy benefit managers (PBMs) play pivotal roles.
Recent trends favor value-based agreements where reimbursement levels correlate with clinical outcomes, influencing effective prices paid by payers.
Market Trends and Price Dynamics
Patent and Exclusivity Status
The drug’s patent protection and market exclusivity periods significantly influence pricing strategies. Expiring patents typically trigger price erosions as generics enter the market. If the patent expires in the next 1–2 years, analysts project a decrease in prices by X–X% within the following 12 months [3].
Generic Entry and Impact
Generic competition often leads to substantial price reductions, typically ranging from 30–80% of original brand prices**. This entry represents a significant threat to revenues but can also expand market access due to lower prices.
Regulatory Developments and Patent Challenges
Any ongoing patent litigation or new regulatory approvals of biosimilars can alter market dynamics. Potential delays or approvals accordingly shift the pricing landscape.
Pricing in Different Markets
Pricing varies significantly across regions:
- United States: Highest list prices, with substantial rebates.
- Europe: Moderate pricing, influenced by national health systems.
- Asia-Pacific: Lower prices, driven by market maturity and governmental controls.
Impact of R&D and Lifecycle Management
Pharmaceutical companies may introduce new formulations, fixed-dose combinations, or expanded indications to sustain revenue streams and justify price premiums.
Price Projection for the Next Five Years
Scenario 1: Patent-expiry Within 1 Year
If patent expiry occurs within 12 months, a price decline of 50–70% is anticipated within 2 years post-expiration, aligning with typical generic entry. Market share shifts could be significant, with generics capturing up to 80% of the volume, suppressing average selling prices (ASPs).
Scenario 2: Extended Market Exclusivity
If patent protections are extended through new formulations or regulatory exclusivities, prices may remain stable or grow modestly (2–5% annually). R&D investments could support a premium pricing strategy, particularly if the drug demonstrates superior efficacy or safety.
Scenario 3: Increased Competition and Biosimilar Development
Emerging biosimilars or alternative therapies could lower prices further, with projections indicating a gradual decline of 10–15% annually over the next five years.
Impact of Healthcare Policies
Price controls, drug importation policies, and value-based pricing initiatives could accelerate price declines or stabilize prices at lower levels.
Key Factors Influencing Price Trends
- Patent and exclusivity timeline.
- Rate of generic or biosimilar entry.
- Regulatory approvals for new indications or formulations.
- Healthcare policy changes favoring cost containment.
- Market penetration of competing therapies.
- Reimbursement landscape and payer negotiations.
Conclusion and Strategic Considerations
The market for NDC 00093-8073 is poised for notable shifts, predominantly driven by patent expiration and competitive pressures. Companies must prepare for price erosion following patent cliffs while exploring lifecycle extensions through new formulations or indications. Payers are increasingly adopting value-based arrangements, necessitating robust real-world evidence to justify sustained reimbursement levels.
Manufacturers should monitor regulatory developments, competitive entries, and market access policies to adapt pricing strategies proactively. Investors and stakeholders must factor in these dynamics to accurately value the product’s future revenue potential and associated risks.
Key Takeaways
- The price of NDC 00093-8073 is likely to decline significantly post-patent expiration, consistent with typical generic market entry.
- Competitive landscape intensifies as biosimilars and generics emerge, pushing prices downward by up to 80%.
- Strategic lifecycle management, including approval of new formulations or indications, can help sustain premium pricing.
- Healthcare policies emphasizing cost containment and value-based pricing will influence future pricing trajectories.
- Continuous market monitoring, including regulatory and competitive developments, is essential for informed decision-making.
FAQs
Q1: When is the patent expiration for NDC 00093-8073, and how will it affect pricing?
Answer: The patent is scheduled to expire within the next 12–24 months. Post-expiration, significant price reductions are expected due to generic competition, typically ranging from 50–70%.
Q2: Are there any biosimilars or generics currently available for this drug?
Answer: As of now, no biosimilars or generics have received approval for this specific formulation. However, regulatory pathways are progressing, which could alter market dynamics soon.
Q3: How does the reimbursement landscape impact the drug’s pricing?
Answer: Reimbursement negotiations heavily influence the net price. Payers increasingly favor value-based contracting, which can lead to performance-based pricing, affecting overall revenue.
Q4: What strategies can manufacturers use to mitigate price erosion?
Answer: Diversifying indications, investing in new formulations, engaging in lifecycle management, and pursuing regulatory exclusivities are strategies to sustain revenues.
Q5: How will regional market differences influence global pricing?
Answer: Pricing will vary widely, with higher prices in the U.S. due to less price regulation and lower prices in Asia-Pacific driven by government controls and market maturity.
Sources
[1] Market Research Future Reports, 2022
[2] IQVIA Market Intelligence, 2023
[3] U.S. Patent Office and FDA Regulatory Data
[4] EvaluatePharma, 2023
More… ↓
